GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible ...
Hosted on MSN
GoodRx announces Wegovy pill availability
GoodRx (GDRX) announced that the newly FDA-approved Wegovy pill is now available at a cash price of $149 per month at more than 70,000 pharmacies nationwide via GoodRx. Published first on TheFly – the ...
Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence “We believe the future of healthcare is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results